Total Voting Rights

RNS Number : 7234U

Allergy Therapeutics PLC

29 June 2009

 



Monday 29 June 2009

Allergy Therapeutics plc

("Allergy Therapeutics" or "the Company")

Total Voting Rights 

Allergy Therapeutics plc (AIM: AGY), the specialist pharmaceutical company focused on allergy vaccination, announces that the Company's share capital consists of 82,366,614 Ordinary 0.1p shares with voting rights attached (one vote per Ordinary share). The company has no shares in Treasury therefore the total number of voting rights in Allergy is 82,366,614.

The above total voting rights figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interests in, or a change to their interest in, Allergy under the FSA's Disclosure and Transparency Rules.

For further information

Allergy Therapeutics	[phone]
Keith Carter, Chief Executive
www.allergytherapeutics.com
Nomura Code Securities	[phone]
Juliet Thompson/ Clare Terlouw
Financial Dynamics	[phone]
Ben Brewerton/ Susan Quigley

 

END

 

 

TVREAKKNADFNEFE